Diagnostic Biomarkers in Metabolomics
A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. A biomarker reveals further information to presently existing clinical and pathological analysis. It facilitates screening and detecting the disease, monitoring the progression of the disease, and predicting the diagnosis and survival after clinical intervention. A biomarker can also be used to evaluate the process of drug development and optimally to improve the efficacy and safety of disease treatment by enabling physicians to tailor treatment for individual patients. These emerging biomarkers will be beneficial and critical in developing new and clinically reliable indicators that will have a high specificity for the diagnosis.
- Biomarkers in drug development
- Disease related biomarkers
- Imaging biomarkers
- Metabolite platform for validation of biomarkers
- Metabolomics in biomarker discovery
Related Conference of Diagnostic Biomarkers in Metabolomics
Diagnostic Biomarkers in Metabolomics Conference Speakers
Recommended Sessions
- Analytical Techniques in Metabolomics
- Cancer Metabolomics
- Clinical and Precision Medicine Metabolomics
- Computational Methodologies
- Diagnostic Biomarkers in Metabolomics
- Disease-Focused Research in Metabolomics
- Edibilomics
- Lipidomics
- Metabolic Modelling and Synthetic Biology
- Metabolomic Devices
- Metabolomic Syndrome
- Metabolomics
- Metabolomics in Drug Discovery
- Plant and Environmental Metabolomics
- Recent Advancements in Metabolomics
- Systems Biology
- Transcriptomics and Proteomics
Related Journals
Are you interested in
- Advanced Biofuels and Sustainable Fuel Technologies - Biodiesel 2027 (France)
- Advanced Imaging and Super-Resolution Techniques - Structural Biology 2026 (Spain)
- Algae-Based Biofuels and Marine Bioenergy - Biodiesel 2027 (France)
- Biogas, Biomethane and Anaerobic Digestion - Biodiesel 2027 (France)
- Biohydrogen and Hydrogen Production from Biomass - Biodiesel 2027 (France)
- Biomass Conversion and Bioenergy Technologies - Biodiesel 2027 (France)
- Biomolecular Dynamics and Allostery - Structural Biology 2026 (Spain)
- Biorefineries and Integrated Biomass Processing - Biodiesel 2027 (France)
- Computational Structural Biology and Artificial Intelligence - Structural Biology 2026 (Spain)
- Cryo-Electron Microscopy (Cryo-EM) - Structural Biology 2026 (Spain)
- Integrative and Hybrid Structural Biology - Structural Biology 2026 (Spain)
- Lignocellulosic Biomass and Cellulosic Biofuels - Biodiesel 2027 (France)
- Membrane Protein Structure and Dynamics - Structural Biology 2026 (Spain)
- Nuclear Magnetic Resonance (NMR) Spectroscopy - Structural Biology 2026 (Spain)
- Protein Engineering and Synthetic Biology - Structural Biology 2026 (Spain)
- Protein Structure and Function - Structural Biology 2026 (Spain)
- Pyrolysis, Gasification and Hydrothermal Conversion - Biodiesel 2027 (France)
- Structural Basis of Genetic and Metabolic Disorders - Structural Biology 2026 (Spain)
- Structural Biology in Drug Discovery - Structural Biology 2026 (Spain)
- Structural Genomics and Proteomics - Structural Biology 2026 (Spain)
- Structural Immunology - Structural Biology 2026 (Spain)
- Sustainable Aviation Fuels and Renewable Transportation - Biodiesel 2027 (France)
- Sustainable Biomass Feedstocks and Supply Chains - Biodiesel 2027 (France)
- Virus Structure and Host Interactions - Structural Biology 2026 (Spain)
- X-ray Crystallography and Diffraction Methods - Structural Biology 2026 (Spain)